Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. (Q39910428)

15 September 2017

title

Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. (English)

1 reference

15 September 2017

1 reference

John B Bossaer

1

1 reference

15 September 2017

Philip D Hall

series ordinal

2

1 reference

15 September 2017

Elizabeth Garrett-Mayer

series ordinal

3

1 reference

15 September 2017

publication date

13 January 2010

1 reference

Supportive Care in Cancer

15 September 2017

published in

1 reference

15 September 2017

volume

19

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

231-237

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-009-0808-y

15 September 2017

exact match

0 references

cites work

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Hematologic effects of linezolid: summary of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0808-Y

Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20069435

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20069435

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00520-009-0808-Y

1 reference

15 September 2017

1 reference